Mentions
Extended reach
Total likes
Video views
AI synopsis
Across the discussions, several users raised questions about the contrasting results of clinical trials and observational data, expressing sentiments like 'the RCTs don't indicate a meaningful difference,' which highlights a critical engagement with the research. Others stated, 'Use of tirzepatide was associated with significantly greater weight loss,' conveying a more straightforward acceptance of the findings. The tone ranges from inquisitive to assertive, reflecting a mix of skepticism and strong belief in the study’s implications.
Most discussions reflect a general support for the article's findings, suggesting that tirzepatide may be more effective than semaglutide for weight loss.
There is a high level of curiosity around the comparative effectiveness of the two medications, as indicated by the number of references and questions raised in the posts.
While many posts provide surface-level comments, some delve into nuances of the findings, including mentions of observational data and personal experiences.
Many users perceive the publication as having a significant impact on understanding treatment options for weight loss in adults with obesity.
Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQpq5uqAQ https://t.co/Cae2rbNyDt
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv
(414/347) #論文マラソン 肥満症に対する効果 マンジャロVSオゼンピック 傾向スコアマッチ マンジャロは体重減少を達成する可能性が有意に高かった。 胃腸系副作用の発生率はグループ間で同様でした。 https://t.co/y4ETWf4K4X
【チルゼパチド vs セマグルチド直接比較（JAMA Intern Med）】 米、電カル4.1万人PSマッチ(52歳,女性71%,110kg)1年追跡 チルゼパチドvsセマグルチドで体重減少達成は 5％以上減少 1.8倍 10％以上減少 2.5倍 15％以上減少 3.2倍 とチルゼパチドが優れる https://t.co/FGFNWdYMX5 https://t.co/622D1ek1QP
Sources: https://t.co/gZRdei8qHi https://t.co/uN5Wo8PTqX https://t.co/k8n7AlaxOA https://t.co/Cho0HF3Jzb https://t.co/liEPKBh7Ka https://t.co/cGCUsVFvYk https://t.co/dLV83WFfHV https://t.co/uN5Wo8PTqX https://t.co/suWt2FTMvL https://t.co/WT2yjpBGHW
Today I’m diving deep into Retatrutide, often called the triple G agonist, and its potential in metabolic health. This innovative compound targets three crucial hormones and has shown remarkable weight loss results…
This video explores a study comparing the weight loss effects of Tirzepatida (Mounjaro) and Semaglutida (Ozempic) in adults with obesity. It highlights that Tirzepatide leads to more significant weight loss outcomes…
8/ For full details, read the study here:
https://t.co/QIK9MeSB6Z
24% Fat Loss? The Truth About Retatrutide (And Why You are Not Ready Yet) https://t.co/k0nu9EAwbi via @YouTube
RT @cremieuxrecueil: Why? Not sure. Speculation welcome! Also note: This was observational data with matching. It lines up with trial data…
Why? Not sure. Speculation welcome! Also note: This was observational data with matching. It lines up with trial data, but there was some discontinuation that attenuates these effects. Source: https://t.co/WT2yjpBGHW
RT @cremieuxrecueil: Sources: https://t.co/gZRdei8qHi https://t.co/uN5Wo8PTqX https://t.co/k8n7AlaxOA https://t.co/Cho0HF3Jzb https://…
Sources: https://t.co/gZRdei8qHi https://t.co/uN5Wo8PTqX https://t.co/k8n7AlaxOA https://t.co/Cho0HF3Jzb https://t.co/liEPKBh7Ka https://t.co/cGCUsVFvYk https://t.co/dLV83WFfHV https://t.co/uN5Wo8PTqX https://t.co/suWt2FTMvL https://t.co/WT2yjpBGHW
RT @jkantor_MD: @drkeithsiau @NEJM https://t.co/qiqYOjRwZe
@drkeithsiau @NEJM https://t.co/qiqYOjRwZe
@MWeintraubMD Thanks. Yes, that is what I was struggling with too. The RCTs don't indicate a meaningful difference nor does EHR mining (see https://t.co/o2Xbp5EcGo) but the anecdotes do. Any theories as to why this discrepancy?
チルゼパチドの体重減少効果より、中止率が気になりました(´･_･`) 【中止率】 ✅ チルゼパチド 55.9% ✅ セマグルチド 52.5% 【要因考察】 ・薬剤の入手困難（供給問題） ・費用負担の問題 ・副作用の問題 ・治療効果への期待とギャップ セマグルチドとチルゼパチドの比較 https://t.co/lFr3Y8dHc1
@magafan1776 @kanyewest Nop, clinical trials said Mounjaro > Ozempic. https://t.co/DQYXu7QVJT
@Abiodun0x Old story, Eli Lilly have their lineup of lineup of diabetes/weight loss drugs (tirzepatide) that are dual-action and probably more effective than Novo’s (semaglutide) https://t.co/o1Bg6uWNka
RT @KirkegaardEmil: https://t.co/st2uROVmjD
https://t.co/st2uROVmjD
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
RT @drraviele: https://t.co/hHuko1nV5k
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
RT @kamleshkhunti: Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQp…
Observational study Tirzepatide associated with significantly greater weight loss than semaglutide https://t.co/ukQpq5uqAQ https://t.co/Cae2rbNyDt
https://t.co/hHuko1nV5k
Most Viewed @JAMAInternalMed 2024: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
RT @rkalyes1:
RT @rkalyes1:
RT @rkalyes1:
RT @rkalyes1:
RT @rkalyes1:
RT @rkalyes1:
RT @rkalyes1:
RT @rkalyes1:
RT @rkalyes1:
RT @rkalyes1:
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/LmcT0HOEeX
https://t.co/lS0bfqh31N
Best ACC 2024 Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity Although most adults with overweight or obesity experienced 5% or greater weight loss with treatment, the benefit was greater with tirzepatide https://t.co/AApb6wqsV6
RT @VipsMDMEd: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/uo0WoZTc3L
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/uo0WoZTc3L
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity doi:10.1001/jamainternmed.2024.2525 https://t.co/3dhZspPqI4
RT @FTustumi: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/cc88OUTXPX
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/cc88OUTXPX
@kosik_md @ParolDamian Są badania porównawcze semaglutydu vs tirzepatydu. 1 https://t.co/hZSaK35T4w
RT @muscle_penguin_: (414/347) #論文マラソン 肥満症に対する効果 マンジャロVSオゼンピック 傾向スコアマッチ マンジャロは体重減少を達成する可能性が有意に高かった。 胃腸系副作用の発生率はグループ間で同様でした。 https://t.co…
RT @JAMAInternalMed: Most viewed in the last 7 days from @JAMAInternalMed: Use of tirzepatide was associated with significantly greater w…
Most viewed in the last 7 days from @JAMAInternalMed: Use of tirzepatide was associated with significantly greater weight loss than semaglutide among adults with overweight or obesity. https://t.co/gi4bxSiTuI https://t.co/WgFD7834MO
RT @JAMAInternalMed: Most viewed in the last 7 days from @JAMAInternalMed: Use of tirzepatide was associated with significantly greater w…
Most viewed in the last 7 days from @JAMAInternalMed: Use of tirzepatide was associated with significantly greater weight loss than semaglutide among adults with overweight or obesity. https://t.co/6lvRwFw5Y2 https://t.co/8022hFpiI5
RT @muscle_penguin_: (414/347) #論文マラソン 肥満症に対する効果 マンジャロVSオゼンピック 傾向スコアマッチ マンジャロは体重減少を達成する可能性が有意に高かった。 胃腸系副作用の発生率はグループ間で同様でした。 https://t.co…
RT @redGDPS:
RT @muscle_penguin_: (414/347) #論文マラソン 肥満症に対する効果 マンジャロVSオゼンピック 傾向スコアマッチ マンジャロは体重減少を達成する可能性が有意に高かった。 胃腸系副作用の発生率はグループ間で同様でした。 https://t.co…
RT @muscle_penguin_: (414/347) #論文マラソン 肥満症に対する効果 マンジャロVSオゼンピック 傾向スコアマッチ マンジャロは体重減少を達成する可能性が有意に高かった。 胃腸系副作用の発生率はグループ間で同様でした。 https://t.co…
(414/347) #論文マラソン 肥満症に対する効果 マンジャロVSオゼンピック 傾向スコアマッチ マンジャロは体重減少を達成する可能性が有意に高かった。 胃腸系副作用の発生率はグループ間で同様でした。 https://t.co/y4ETWf4K4X
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity a real world study showing Tirzepatide more efficacious https://t.co/0wEfNvsMIh
Semaglutida frente a tirzepatida para perder peso en adultos con obesidad o sobrepeso https://t.co/m7KiwnVtnl PMID 38976257
In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater weight loss than semaglutide (ozempic). https://t.co/lTzBpypkxE
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/vk5sCnoYnZ
@STANLEES4 還有更有效的 https://t.co/NVw95PxVr6
RT @kamleshkhunti: Observational data from US in people with T2 diabetes Propensity matched Tirzepatide had greater weight loss vs semagl…
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity | Obesity | JAMA Internal Medicine | JAMA Network https://t.co/yfVXykjRCp
Head-to-head #drug comparisons are important. #healthcare https://t.co/upyimkMbSa
RT @kamleshkhunti: Observational data from US in people with T2 diabetes Propensity matched Tirzepatide had greater weight loss vs semagl…
RT @kamleshkhunti: Observational data from US in people with T2 diabetes Propensity matched Tirzepatide had greater weight loss vs semagl…
RT @kamleshkhunti: Observational data from US in people with T2 diabetes Propensity matched Tirzepatide had greater weight loss vs semagl…
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/m8IjQGf6Ut
Observational data from US in people with T2 diabetes Propensity matched Tirzepatide had greater weight loss vs semaglutide Side effects similar https://t.co/zNVv3OmF4N https://t.co/il7tT7AYUt
RT @FormigaFrancesc: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/kJL5Bsoprg
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/kJL5Bsoprg
Mounjaro is more effective than Ozempic for weight loss. Not an advertisement or endorsement for either. Just sharing the facts. https://t.co/H1fjxm4aXx https://t.co/5x2LNF7MMa
There's this recent retrospective cohort comparison study broadly concluding tirzepatide is more effective than semaglutide for #weightloss via multiple statistical analyses, but I couldn't find details on doses even in the Supplementals: https://t.co/tmlbpf678t 3/
@elonmusk @TheRabbitHole84 The problem with semaglutide and tirzepatide are the side effects. I could benefit from either of those drugs, but the side effects with my particular medical conditions prevent me from taking them. https://t.co/W39yVwyoTS
RT @scottisaacsmd: Study of #semaglutide vs #tirzepatide for weight loss. Tirzepide is the clear winner in terms of percentage of weight lo…
Use of tirzepatide may be associated with significantly more weight loss compared with semaglutide in patients with overweight or obesity. @Dxgnosis @truveta @JAMAInternMed https://t.co/I77jdpQ27X
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/cyJaJFA6Ky
RT @AlaaBabonji: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/2RFerKH3eI
RT @AlaaBabonji: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/2RFerKH3eI
RT @DrYousefAlsaleh: في دراسة جديدة تمت فيها مقارنة النتائج ل ٤١ الف مستخدم: مونجارو افضل من اوزمبك في فقد الوزن للمصابين بزيادة الوزن او ا…
RT @DrYousefAlsaleh: في دراسة جديدة تمت فيها مقارنة النتائج ل ٤١ الف مستخدم: مونجارو افضل من اوزمبك في فقد الوزن للمصابين بزيادة الوزن او ا…
في دراسة جديدة تمت فيها مقارنة النتائج ل ٤١ الف مستخدم: مونجارو افضل من اوزمبك في فقد الوزن للمصابين بزيادة الوزن او السمنة سواءا كانو مصابين بالسكري ام لا رابط الدراسة : doi:10.1001/jamainternmed.2024.2525 https://t.co/4wsWRhTxFp
RT @BITNavarra: (JAMA) Semaglutida vs tirzepatida en pérdida de peso en pacientes con sobrepeso u obesidad https://t.co/UfkhWRfHm9
Dans une population d'adultes en surpoids ou obèses, l'utilisation de tirzépatide a été associée à une perte de poids significativement plus importante que pour le sémaglutide. https://t.co/f3cV5pLnlT
RT @JaimePonceMD: Real world data weight loss at 1 year: Semaglutide 8.3% Tirzepatide 15.3% https://t.co/9deC5g4KT3. @ASMBS @IfsoSecretari…
RT @JaimePonceMD: Real world data weight loss at 1 year: Semaglutide 8.3% Tirzepatide 15.3% https://t.co/9deC5g4KT3. @ASMBS @IfsoSecretari…
https://t.co/lsZFv5xEhh W populacji osób dorosłych z nadwagą lub otyłością stosowanie tirzepatydu wiązało się ze znacznie większą utratą masy ciała niż stosowanie semaglutydu.
@kotyathegreat With respect to what? For weight loss, I believe there is some data suggesting greater weight loss with tirzepatide (see link to observational study below) though the decision on what medication to use depends on a number of factors https://t.co/yknPGh2XJQ
(JAMA) Semaglutida vs tirzepatida en pérdida de peso en pacientes con sobrepeso u obesidad https://t.co/UfkhWRfHm9
RT @FarmaMadridAP: (JAMA) Semaglutida vs tirzepatida en pérdida de peso en pacientes con sobrepeso u obesidad. https://t.co/2ZzzZadSsy http…
(JAMA) Semaglutida vs tirzepatida en pérdida de peso en pacientes con sobrepeso u obesidad. https://t.co/2ZzzZadSsy https://t.co/0QBKEQwj11
(JAMA Intern Med) Eficacia en la pérdida de peso de semaglutida vs tirzepatida en pac con sobrepeso u obesidad https://t.co/Hqquz1S48t Est Observ https://t.co/lUjv0z4yNH
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zrKkbwofua
RT @zaptrapped: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/Y9zuHgNVjY
RT @zaptrapped: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/Y9zuHgNVjY
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/Y9zuHgNVjY
RT @truveta: With more than 100K views in <3 weeks, Truveta Research's peer-reviewed publication comparing #WeightLoss among patients on #s…
With more than 100K views in <3 weeks, Truveta Research's peer-reviewed publication comparing #WeightLoss among patients on #semaglutide vs. #tirzepatide is the most popular study in @JAMAInternalMed this month.
Tirzepatida Dobla la Eficacia de Semaglutida en la Pérdida de Peso para Pacientes con Obesidad Severa, Revela Estudio de JAMA Internal Medicine https://t.co/fHmUknV46y https://t.co/GPUqOg8jMX
RT @JAMAInternalMed: In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater…
RT @JAMAInternalMed: In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater…
Every day something get pub. to compare Sema vs Tirz This time a retrospective observational cohort study - commissioned by https://t.co/XxafeSFWbH In 41 222 pts: Tirz > Sema https://t.co/YvHKnyYZwZ Also, Lily's SURMOUNT-5 Ph3b study h-t-h Tirz vs Sema readouts late 2024 https://t.co/U2ebTbATP9
RT @JAMAInternalMed: In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater…
In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater weight loss than semaglutide. https://t.co/VRVA5WsOXi https://t.co/aGHaJvL6Yp
RT @dr_ukio: 【チルゼパチド vs セマグルチド直接比較（JAMA Intern Med）】 米、電カル4.1万人PSマッチ(52歳,女性71%,110kg)1年追跡 チルゼパチドvsセマグルチドで体重減少達成は 5％以上減少 1.8倍 10％以上減少 2.5…
RT @Pon_yurublog: GLP-1作動薬のセマグルチド、チルゼパチドの減量効果を直接比較したn=1万8千人のJAMA Intern Medの論文 ☑︎ RCTではなく、コホート研究ですが、参加者がめちゃくちゃ多い ☑︎ 結果はチルゼパチドの方が効果が高かった（チ…
GLP-1作動薬のセマグルチド、チルゼパチドの減量効果を直接比較したn=1万8千人のJAMA Intern Medの論文 ☑︎ RCTではなく、コホート研究ですが、参加者がめちゃくちゃ多い ☑︎ 結果はチルゼパチドの方が効果が高かった（チルゼパチドはGLP-1、GIPの両方の受容体の作動薬） https://t.co/feY4EfVkOR https://t.co/V3HNFBRuAw
RT @dr_ukio: 【チルゼパチド vs セマグルチド直接比較（JAMA Intern Med）】 米、電カル4.1万人PSマッチ(52歳,女性71%,110kg)1年追跡 チルゼパチドvsセマグルチドで体重減少達成は 5％以上減少 1.8倍 10％以上減少 2.5…
RT @fperrywilson: You can find the manuscript here: https://t.co/hp5gf9r0BU and my more detailed piece here @medscape: https://t.co/teFEvm…
RT @dr_ukio: 【チルゼパチド vs セマグルチド直接比較（JAMA Intern Med）】 米、電カル4.1万人PSマッチ(52歳,女性71%,110kg)1年追跡 チルゼパチドvsセマグルチドで体重減少達成は 5％以上減少 1.8倍 10％以上減少 2.5…
【チルゼパチド vs セマグルチド直接比較（JAMA Intern Med）】 米、電カル4.1万人PSマッチ(52歳,女性71%,110kg)1年追跡 チルゼパチドvsセマグルチドで体重減少達成は 5％以上減少 1.8倍 10％以上減少 2.5倍 15％以上減少 3.2倍 とチルゼパチドが優れる https://t.co/FGFNWdYMX5 https://t.co/622D1ek1QP
#Obesidad
❓Is tirzepatide more effective as semaglutide to achieve weight loss in individuals with overweight or obesity?
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/imY8Gb9Pj4
Trend up+5: Rodriguez PJ, ..., Stucky NL (JAMA Intern Med) __Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity__ https://t.co/1Suhlirwdt
【コホート研究】過体重または肥満の成人において、チルゼパチドの使用は、セマグルチドの使用と比較して、より大きな体重減少と関連した。 #ペ読 https://t.co/HPRXNf5TJd
RT @EricTopol: From a cohort with matched propensity analysis, the weight loss achieved from tirzepatide was substantially greater than wit…
RT @JAMAInternalMed: Most viewed in the last 7 days from @JAMAInternalMed: How does weight loss differ between patients receiving tirzepat…
July 8 Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/XIDivjqMGK
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/ncSKWsH1nJ En la batalla de los pesos, este estudio de cohorte (con los sesgos propios) documenta una mayor pérdida de peso con TIRZEPATIDE COMPARADO SEMAGLUTIDE .
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/2RFerKH3eI
#Semaglutide vs #Tirzepatide for Weight Loss in Adults With Overweight or Obesity | JAMA Internal Medicine https://t.co/JUxp73ZdVC
Trend up+6: Rodriguez PJ, ..., Stucky NL (JAMA Intern Med) __Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity__ https://t.co/1Suhlirwdt
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity / Semaglutida frente a tirzepatida para bajar de peso en adultos con sobrepeso u obesidad https://t.co/TUk6aP3MDN
RT @mdballesteros: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/nfBG0HENeV
RT @mdballesteros: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/I0syuehYT8
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/eMSVhbQYdM
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity | Obesity | JAMA Internal Medicine | JAMA Network https://t.co/yfVXykjRCp
Trend up+523: Rodriguez PJ, ..., Stucky NL (JAMA Intern Med) __Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity__ https://t.co/1Suhlirwdt
RT @mdballesteros: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv
RT @mdballesteros: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity Although most adults with overweight or obesity experienced 5% or greater weight loss with treatment, the benefit was greater with tirzepatide https://t.co/AApb6wpV5y
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/XRkYWEPhBH
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/RIouKIJIR0
RT @mdballesteros: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/x4FWXKAQjj
セマグルチドとチルゼパチドを比較したコホート研究が出てたので、GPTさんにまとめてもらった。 Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/M6VapLDwmX https://t.co/HEuUh0RJW9
obesidad y apnea del sueño. Semaglutida frente a tirzepatida para bajar de peso en adultos con sobrepeso u obesidad doi:10.1001/jamainternmed.2024.2525
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity | Obesity | JAMA Internal Medicine | JAMA Network https://t.co/EWOJAvpbfe
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/tf8KXrdQQj
RT @mdballesteros: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv
RT @mdballesteros: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv
RT @mdballesteros: Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity https://t.co/zO0Dc8mkgv